Write a 100-350 word essay about human IDUA: it function, reaction pathways it participates in, where it is located and diseases related to it.  Provide 3-5 key references where I can find more information.

Alpha-L-iduronidase (IDUA) is an essential lysosomal enzyme in humans, encoded by the IDUA gene. It plays a crucial role in the degradation of glycosaminoglycans (GAGs), specifically dermatan sulfate and heparan sulfate. The deficiency of IDUA leads to the accumulation of these GAGs in the body, causing various health issues.

Functionally, IDUA catalyzes the hydrolysis of terminal alpha-L-iduronic acid residues in dermatan sulfate and heparan sulfate. This enzymatic activity is critical for the normal turnover and degradation of GAGs, complex carbohydrates involved in various cellular functions, including cell signaling, tissue repair, and structural integrity.

IDUA participates in the lysosomal degradation pathway of GAGs. Its deficiency impairs the breakdown of dermatan sulfate and heparan sulfate, leading to their accumulation within lysosomes. This accumulation disrupts normal cellular function and can result in cellular and tissue damage.

IDUA is primarily located in lysosomes, the cellular organelles responsible for breaking down and recycling various biomolecules. Lysosomes act as the cell's waste disposal system, and enzymes like IDUA are crucial for their efficient functioning.

Diseases associated with IDUA deficiency are categorized under mucopolysaccharidosis (MPS), a group of rare autosomal recessive disorders. The most common form associated with IDUA deficiency is MPS type I, which presents in varying degrees of severity. MPS type I encompasses Hurler syndrome (the most severe form), Hurler-Scheie syndrome (intermediate severity), and Scheie syndrome (the mildest form). These conditions are characterized by symptoms like skeletal abnormalities, developmental delay, organomegaly, and in severe cases, neurological impairment​​.

For more detailed information on IDUA, the following references are recommended:

"Mucopolysaccharidosis Type I" in the journal "Genetics in Medicine" for comprehensive information on the disease caused by IDUA deficiency.
"Lysosomal Storage Diseases: Diagnosis and Treatment" in the Journal of the American Medical Association for clinical insights into diseases related to lysosomal enzyme deficiencies.
"The Metabolic and Molecular Bases of Inherited Disease" for an in-depth understanding of metabolic pathways affected by enzyme deficiencies.
"Essentials of Glycobiology" (3rd Edition) by A. Varki, R.D. Cummings, J.D. Esko, et al., for a broad overview of glycosaminoglycans and their metabolism.
These resources will provide comprehensive insights into the role of IDUA in human physiology and its association with mucopolysaccharidosis.